Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Clinical trial NCT04356222 · UNKNOWN
Trial details
- NCT number
- NCT04356222
- Sponsor
- Hui Bu
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.